Free Trial
→ Bank of America: 'Digital Dollar Inevitable' (From Decentralized Masters) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
C$14.99
+1.4%		C$15.41
C$7.59
▼
C$17.64
C$525.65M3.8161271,108 shs350 shs
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
C$4.97
+2.7%		C$5.00
C$2.51
▼
C$5.50
C$156.19M0.71336345,495 shs6,701 shs
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$2.65
+3.9%		$3.74
$2.48
▼
$15.70
$391.64M1.914.23 million shs5.10 million shs
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$21.28
+6.2%		$21.11
$12.71
▼
$31.05
$7.98M0.9820,007 shs5,266 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
-0.27%+3.79%+1.93%+6.79%+27.61%
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
-1.83%-0.62%+2.54%-3.01%+72.86%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
+0.79%-6.25%-29.36%-45.04%-80.97%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
+6.77%+5.58%-2.72%+3.51%+5.22%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
C$14.99
+1.4%		C$15.41
C$7.59
▼
C$17.64
C$525.65M3.8161271,108 shs350 shs
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
C$4.97
+2.7%		C$5.00
C$2.51
▼
C$5.50
C$156.19M0.71336345,495 shs6,701 shs
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$2.65
+3.9%		$3.74
$2.48
▼
$15.70
$391.64M1.914.23 million shs5.10 million shs
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$21.28
+6.2%		$21.11
$12.71
▼
$31.05
$7.98M0.9820,007 shs5,266 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
-0.27%+3.79%+1.93%+6.79%+27.61%
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
-1.83%-0.62%+2.54%-3.01%+72.86%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
+0.79%-6.25%-29.36%-45.04%-80.97%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
+6.77%+5.58%-2.72%+3.51%+5.22%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
4.00
Strong BuyN/AN/A
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
0.00
N/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.38
Hold$5.90122.64% Upside
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest MDP, TLRY, FRX, and WEED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/23/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
10/9/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetHold$4.50 ➝ $4.00
10/8/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
10/5/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
TD logo
TD
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$4.70 ➝ $4.50
9/29/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeHold ➝ Strong Sell
9/21/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
9/21/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
ATB Cormark Capital Markets logo
ATB Cormark Capital Markets
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetHold$8.00 ➝ $6.00
8/24/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
8/7/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
(Data available from 11/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
C$59.22M8.88C$1.29 per share11.66C$1.23 per share12.21
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
C$103.30M1.51N/AN/AC$1.51 per share3.30
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$915.45M0.43N/AN/A$10.87 per share0.24
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
-C$800.44K-C$0.12N/AN/AN/A-6.21%-13.34%8.88%N/A
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
C$3.26M-C$0.07N/AN/AN/A-2.29%-4.69%4.89%N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$121.40M-$1.40N/AN/AN/A-16.91%-10.39%-7.38%1/11/2027 (Estimated)
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest MDP, TLRY, FRX, and WEED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/8/2026Q1 2027
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.1814-$0.02+$0.1614-$0.32$266.26 million$257.15 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
N/A2.02%N/AN/AN/A
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
N/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
N/AN/AN/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
N/A
5.85
10.17
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
54.62
1.30
N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.17
1.88
1.11
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
16.50%
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
3.98%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
9.35%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A

Insider Ownership

CompanyInsider Ownership
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
16.20%
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
9.14%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
1.60%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
1035.07 millionN/ANot Optionable
Medexus Pharmaceuticals Inc. stock logo
MDP
Medexus Pharmaceuticals
9031.43 millionN/ANot Optionable
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
3,595147.79 million145.42 millionOptionable
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A375,000N/ANot Optionable

Recent News About These Companies

Roundhill Cannabis ETF (BATS:WEED) Share Price Breaks Above Two Hundred Day Moving Average - Time to Sell?
November 3 at 3:53 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31175732
Roundhill Cannabis ETF (BATS:WEED) Shares Shorted: Short Interest Down 46.9% in October
October 31 at 3:41 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31169840
Cours Roundhill Cannabis ETF - USD
September 13, 2026  |  zonebourse.comZ
Roundhill Cannabis ETF
August 18, 2026  |  markets.ft.comhttps://markets.ft.com/data/etfs/tearsheet/summary?s=WEED:BTQ:USD
Listed Funds Trust - Roundhill Cannabis ETF
June 24, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/weed-listed-funds-trust-roundhill-cannabis-etf
5 ETFs Up At Least 5% Last Week's Market Rout
June 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2935285/5-etfs-up-at-least-5-last-week-s-market-rout?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2935285
100 Days Into the Iran War: Winning & Losing ETF Areas
June 8, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2933607/100-days-into-the-iran-war-winning-losing-etf-areas?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2933607
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
May 14, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2921525/us-reclassifies-weed-can-cannabis-etfs-give-your-portfolio-a-new-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2921525
Sector ETFs rally in April despite inflation and growth concerns
May 5, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/sector-etfs-rally-in-april-despite-inflation-and-growth-concerns/gm-GMBF0D3441
Best-Performing ETFs of April
May 5, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2914473/best-performing-etfs-of-april?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2914473
Cannabis ETFs: Regulatory Momentum Returns Focus
April 30, 2026  |  etftrends.comE
ETF sectors rally on chip surge, cannabis gains, oil jump
April 29, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/etf-sectors-rally-on-chip-surge-cannabis-gains-oil-jump/gm-GM17BC3388
ETF sectors rally as healthcare CapEx growth accelerates
April 28, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/etf-sectors-rally-as-healthcare-capex-growth-accelerates/gm-GM8CDC252B
Semiconductors, cannabis ETFs lead gains as sector rotation accelerates
April 28, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/semiconductors-cannabis-etfs-lead-gains-as-sector-rotation-accelerates/gm-GM7C8E74D8
4 Best-Performing ETF Areas of Last Week
April 28, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2909237/4-best-performing-etf-areas-of-last-week?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2909237
How to buy marijuana stocks: A beginner’s guide
March 27, 2026  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/how-to-buy-marijuana-stocks-a-beginner-s-guide/ar-AA1V1gHo
Roundhill Cannabis ETF : WEED
March 24, 2026  |  247wallst.comhttps://247wallst.com/companies/weed/
Santa Rally Falls Short: Top ETF Performers of December
January 2, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2811211/santa-rally-falls-short-top-etf-performers-of-december?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2811211
Cannabis ETFs surge on Trump's reclassification review
December 18, 2025  |  msn.comhttps://www.msn.com/en-xl/news/other/cannabis-etfs-surge-on-trump-s-reclassification-review/ar-AA1SA2lM
Cannabis ETF (WEED) Hits a New 52-Week High
December 17, 2025  |  zacks.comhttps://www.zacks.com/stock/news/2805373/cannabis-etf-weed-hits-a-new-52-week-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2805373

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Salesforce cloud logo in a futuristic tech setting, highlighting CRM enterprise software and AI platform growth.
Salesforce Fuels AI Engine With $5.66B Braze Buyout
By Jeffrey Neal Johnson | October 21, 2026
Kalshi and Polymarket logos beside a smartphone showing a prediction market on the Chiefs winning the Super Bowl, with a football in the background.
Want Private-Market Access to Kalshi and Polymarket? Try This ETF
By Jessica Mitacek | October 8, 2026
White Tesla sports car parked at a launch site with rocket boosters visible against a sunset sky.
Tesla's Roadster Reveal Hints at 2 Much Bigger Moves
By Sam Quirke | October 19, 2026
Tilray logo overlaid on a cannabis cultivation and processing facility with plants and packaged product jars.
Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
By Jeffrey Neal Johnson | October 9, 2026
Rows of flowering cannabis plants grow under industrial grow lights inside a commercial indoor cultivation facility.
Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
By Jeffrey Neal Johnson | October 6, 2026
Fennec Pharmaceuticals stock logo

Fennec Pharmaceuticals TSE:FRX

C$14.99 +0.20 (+1.35%)
As of 03:59 PM Eastern

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy. Fennec is focused on the commercialization of PEDMARK® to reduce the risk of platinum-induced ototoxicity in cancer patients. PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and United Kingdom ( U.K. ) approval in October 2023 under the brand name PEDMARQSI®. In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, with rights to commercialize PEDMARQSI® in Europe, U.K., Australia and New Zealand. PEDMARQSI is now commercially available in the U.K. and Germany. PEDMARK has received Orphan Drug Exclusivity in the U.S. and PEDMARQSI has received Pediatric Use Marketing Authorization in Europe which includes eight years plus two years of data and market protection.

Medexus Pharmaceuticals stock logo

Medexus Pharmaceuticals TSE:MDP

C$4.97 +0.13 (+2.69%)
As of 03:59 PM Eastern

Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus's current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.

Tilray Brands stock logo

Tilray Brands NASDAQ:TLRY

$2.65 +0.10 (+3.92%)
Closing price 04:00 PM Eastern
Extended Trading
$2.67 +0.02 (+0.79%)
As of 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Roundhill Cannabis ETF stock logo

Roundhill Cannabis ETF BATS:WEED

$21.28 +1.24 (+6.19%)
Closing price 04:10 PM Eastern
Extended Trading
$21.24 -0.04 (-0.16%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas